Monitoring Agency Report

<= VINEET Vineet Laboratories Limited Regd.Offce: SY.No. 1/A3, Sahab Nagr C, K N-u r Ld 2u V 3i 0, C Th Gi 2n 0a 1l K Pu Ln Ct 1a, 2E 8s 8h 8w aramma Nilayam, L B Nagar Hyderabad. Phone: 040-24126833; Emall Ig; cs@vineellabs.co.n; Website: vineslabscoln 14 August, 2026 To National Stock Exchange of India Limited, B PhS iE L zi em i Jt ee ed j, eebhoy Towers, Exchange Plaza, C-1, Block G, Bandra Kurla Complex, Dalal Street, Mumbai- 400 001. Bandra (E), Mumbai — 400 051. BSE Scrip Code: 543298 NSE Scrip Code: VINEETLAB Dear Sir/ Ma'am, Sub: Monitoring Agency Report for the quarter ended June 30, 2026 Pursuant to the above-captioned subject, please find enclosed herewith the Monitoring Agency Report dated August 14, 2026, for the quarter ended June 30, 2026. The said Monitoring Agency Report has been issued by Crisil Ratings Limited, the Monitoring Agency appointed by the Company for monitoring the utilization of funds raised through the Rights Issue of the Company. The aforesaid Monitoring Agency Report is enclosed herewith as Annexure-1 for your information and records. Thanking you, Yours faithfully, For Vineet Laboratories Limited Gaddam Venkata Ramana Director DIN: 00031873 G‘ Scanned with OKEN Scanner Crisil Ratings Monitoring Agency Report Vineet Laboratories Limited for the quarter ended June 30, 2026 risil Ratings Limited orporate Identity Number: U67100MH2019PLC326247 d Office: Lightbridge IT Park, Saki Vihar Road, Andheri East, Mumbai40-0 072. India hone: +91 22 6137 30| 0www0.c m acompany of S&P Global Crisil Ratings CRL/MAR/ VILALI/2026-27/1890 August 14, 2026 Vineet Laboratories Limited Sy. No. 11/ A3, Saheb Nagar, Kurdu Vill, Chintal Kunta, Eshwaramma Nilayam L B Nagar, Hyderabad, Telangana - 500074 Dear Sir, Sub: Monitoring Agency Report for the quarter ended June 30, 2026 - in relation to the Rights Issue of Vineet Laboratories Limited (“the Company”) Pursuant to Regulation 82(2) of SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 (“ICDR Regulations”) and Monitoring Agency Agreement dated November 27, 2025, entered with the Company, we enclose the Monitoring Agency Report, issued by Crisil Ratings Limited, as per Schedule XI of the SEBI ICDR Regulations towards utilization of proceeds of Rights Issue for the quarter ended June 30, 2026. Request you to kindly take the same on records. Thanking you, For and on behalf of Crisil Ratings Limited Director, Ratings (LCG) Crisil Ratings Limited Corporate Identity Number: U67100MH2019PLC326247 Registered Office: Lightbridge IT Park, Saki Vihar Road, Andheri East, Mumbai- 400 072. India Phone: +31 22 6137 3000 | www.crisilratings.com acompany of S&P Global Crisil Ratings Report of the Monitoring Agency Name of the issuer: Vineet Laboratories Limited For quarter ended: June 30, 2026 Name of the Monitoring Agency: Crisil Ratings Limited (a) Deviation from the objects: Not applicable (b) Range of Deviation: Not applicable Declaration: T\e declare that this report provides an objective view of the utilization of the issue proceeds in relation to the objects of the issue based on the information provided by the Issuer and information obtained from sources believed by it to be accurate and reliable. The MA does not perform an audit and undertakes no independent verification of any information/ certifications/ statements it recetves. This Report is not intended to create any legally binding obligations on the MA which accepts no responsibility, whatsoeverfo,r loss or damage front the use of the said information. The views and opinions expressed herein do not constitute the opinion of MA to deal in any security of the Issuer in any manner whatsoever. Nothing mentioned in this report is intended to or should be construed as creating a fiduciary relationship between the MA and any issuer or between the agency and any user of this report. The MA and its affiliates also do not act as an expert as defined under Section 2(38) of the Companies Act, 2013. The MA or its affiliates may have credit rating or other commercial transactions with the entity to which the report pertains and may receive separate compensatiofonr its ratings and certain credit-related analyses. VVe confirm that we do not perceive any conflict of interest in such relationship/interest while monitoring and reporting the utilization of the issue proceeds by the issuer. T\ have submitted the report herewith in line with the format prescribed by SEBL, capturing our contments, where applicable. There are certain sections of the report under the title “Comments of the Board of Directors”, that shall be captured by the Issuer’s Managem/e Anudtit Committee of the Board of Directors subsequent to the MA submitting their report to the issiuer and before dissemination of the report through stock exchanges. These sections have not been reviewed by the MA, and the MA takes no responsibiliftoyr such comments of the issuer’s Management/Board. Signature: M Name and designation of the Aythorized Signatory: Shounak Chakravarty Designation of Authorized person/Signing Authority: Director, Ratings (LCG) Crisil Ratings Limited Corporate Identity Number: U67100MH2019PLC326247 RPheognies:t er+e9d1 O2f2fi c1e:3 7L i3g0h0tb0r |i dwgwew .IcTr Piasrikl,r aStaikin gVsi.hcaorm Road, Andheri East, Mumbai- 400 072. India acompany of S&P Global Crisil Ratings 1) Issuer Details: Name of the issuer: Vineet Laboratories Limited Names of the promoter: Mr. Satyanarayana Raju Bhupathiraju Mr. V Varaprasada Rao Mr. A Srinivasa Raju Mr. A Ranga Raju Mr. A Prabhakar Raju Mr. Alluri Mythili Mr. Gaddam Venkata Ramana Mr. Alluri Anantha Laxmi Mr. Gaddam Venkata Rama Mr. Kandula Murali Mohan Mr. Penmetsa Venkata Krishnam Raju Mr. P Kishore Raju Mr. Gaddam Srinivasarao Mr. Gaddam Balaji Industry/sector to which it belongs: Pharmaceuticals 2) Issue Details Issue Period: January 01, 2026, to January 21, 2026 Type of issue (public/rights): Rights Issue Type of specified securities: Equity Shares IPO Grading, if any: NA Issue size: Issue size comprises of gross proceeds of Rs. 2,996.81 lakhs (Net proceeds of Rs. 2,921.18 lakhs *). *Crisil Ratings shall be monitoring the gross proceeds anount 3) Details of the arrangement made to ensure the monitoring of issue proceeds: Source of information / certifications Comments of | Comments of Particulars Reply considered by the Monitoring | the Board of Monitoring Agency for Agency Directors preparation of report Statuto.r}.r Auditor Proceeds have certificate”, s Management been utilized Whether all utilization is as per the gem towards issue No . . Yes undertaking, X disclosures in the Offer Document? expenses as in Comments Letter of Offer dated line with th December 17,2025, Bank | 201¢ Statements Crisil Ratings Limited Corporate Identity Number: U67100MH2019PLC326247 Registered Office: Lightbridge IT Park, Saki Vihar Road, Andheri East, Mumbai- 400 072. India Phone: +31 22 6137 3000 | www.crisilratings.com acompany of S&P Global Crisil Ratings Source of information / certifications Comments of | Comments of Particulars Reply considered by the Monitoring | the Board of Monitoring Agency for Agency Directors preparation of report Whether shareholder approval has been obtained in case of material No deviations ~ from expenditures NA No Comments Comments disclosed in the Offer Document? Whether the means of finance for the No disclosed objects of the issue has | NA No Comments Comments changed? Is there any major deviation observed No over the earlier monitoring agency NA No Comments Comments reports? Statutory Auditor certificate”, Whether all Government/statutory Management No approvals related to the object(s) | NA undertaking No Comments | - have been obtained? Whether all arrangements pertaining No to technical assistance/collaboration NA No Comments s . Comments are in operation? Are there any favorable events No improving the viability of these No No Comments Comments object(s)? Are there any unfavorable events No [Showing first 8,000 characters — download PDF for full document]